Abstract
Background
Clinical translation of the extracorporeal artificial placenta (AP) is impeded by the high risk for intracranial hemorrhage in extremely premature newborns. The Nitric Oxide Surface Anticoagulation (NOSA) system is a novel non-thrombogenic extracorporeal circuit. This study aims to test the NOSA system in the AP without systemic anticoagulation.
Methods
Ten extremely premature lambs were delivered and connected to the AP. For the NOSA group, the circuit was coated with DBHD-N2O2/argatroban, 100 ppm nitric oxide was blended into the sweep gas, and no systemic anticoagulation was given. For the Heparin control group, a non-coated circuit was used and systemic anticoagulation was administered.
Results
Animals survived 6.8 ± 0.6 days with normal hemodynamics and gas exchange. Neither group had any hemorrhagic or thrombotic complications. ACT (194 ± 53 vs. 261 ± 86 s; p < 0.001) and aPTT (39 ± 7 vs. 69 ± 23 s; p < 0.001) were significantly lower in the NOSA group than the Heparin group. Platelet and leukocyte activation did not differ significantly from baseline in the NOSA group. Methemoglobin was 3.2 ± 1.1% in the NOSA group compared to 1.6 ± 0.6% in the Heparin group (p < 0.001).
Conclusions
The AP with the NOSA system successfully supported extremely premature lambs for 7 days without significant bleeding or thrombosis.
Impact
-
The Nitric Oxide Surface Anticoagulation (NOSA) system provides effective circuit-based anticoagulation in a fetal sheep model of the extracorporeal artificial placenta (AP) for 7 days.
-
The NOSA system is the first non-thrombogenic circuit to consistently obviate the need for systemic anticoagulation in an extracorporeal circuit for up to 7 days.
-
The NOSA system may allow the AP to be implemented clinically without systemic anticoagulation, thus greatly reducing the intracranial hemorrhage risk for extremely low gestational age newborns.
-
The NOSA system could potentially be applied to any form of extracorporeal life support to reduce or avoid systemic anticoagulation.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 14 print issues and online access
$259.00 per year
only $18.50 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Data availability
The datasets generated and analyzed during the current study are available from the corresponding author on reasonable request.
References
Stoll, B. J. et al. Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network. Pediatrics 126, 443–456 (2010).
Church, J. T. et al. Pushing the boundaries of ECLS: outcomes in <34 week EGA neonates. J. Pediatr. Surg. 52, 1810–1815 (2017).
Church, J. T. et al. The artificial placenta: continued lung development during extracorporeal support in a preterm lamb model. J. Pediatr. Surg. 53, 1896–1903 (2018).
Church, J. T. et al. Perfluorocarbons prevent lung injury and promote development during artificial placenta support in extremely premature lambs. Neonatology 113, 313–321 (2018).
Church, J. T. et al. Effects of an artificial placenta on brain development and injury in premature lambs. J. Pediatr. Surg. 53, 1234–1239 (2018).
Coughlin, M. A. et al. An artificial placenta protects against lung injury and promotes continued lung development in extremely premature lambs. ASAIO J. 65, 690–697 (2019).
El-Sabbagh, A. M. et al. Cerebral oxygenation of premature lambs supported by an artificial placenta. ASAIO J. 64, 552–556 (2018).
McLeod, J. S. et al. Splenic development and injury in premature lambs supported by the artificial placenta. J. Pediatr. Surg. 54, 1147–1152 (2019).
McLeod, J. S. et al. Gastrointestinal mucosal development and injury in premature lambs supported by the artificial placenta. J. Pediatr. Surg. 53, 1240–1245 (2018).
Nasr, V. G. et al. Highlights from the Extracorporeal Life Support Organization Registry: 2006–2017. ASAIO J. 65, 537–544 (2019).
Hardart, G. E., Hardart, M. K. M. & Arnold, J. H. Intracranial hemorrhage in premature neonates treated with extracorporeal membrane oxygenation correlates with conceptional age. J. Pediatr. 145, 184–189 (2004).
Fallon, B. P. et al. A pumpless artificial lung without systemic anticoagulation: the Nitric Oxide Surface Anticoagulation system. J. Pediatr. Surg. 57, 26–33 (2022).
Major, T. C. et al. The effect of a polyurethane coating incorporating both a thrombin inhibitor and nitric oxide on hemocompatibility in extracorporeal circulation. Biomaterials 35, 7271–7285 (2014).
Handa, H. et al. In vitro and in vivo study of sustained nitric oxide release coating using diazeniumdiolate-doped poly(vinyl chloride) matrix with poly(lactide-co-glycolide) additive. J. Mater. Chem. B 1, 3578 (2013).
Batchelor, M. M. et al. More lipophilic dialkyldiamine-based diazeniumdiolates: synthesis, characterization, and application in preparing thromboresistant nitric oxide release polymeric coatings. J. Med. Chem. 46, 5153–5161 (2003).
Qin, Y. et al. Portable nitric oxide (NO) generator based on electrochemical reduction of nitrite for potential applications in inhaled no therapy and cardiopulmonary bypass surgery. Mol. Pharm. 14, 3762–3771 (2017).
Bryner, B. et al. An extracorporeal artificial placenta supports extremely premature lambs for 1 week. J. Pediatr. Surg. 50, 44–49 (2015).
Major, T. C. et al. The attenuation of platelet and monocyte activation in a rabbit model of extracorporeal circulation by a nitric oxide releasing polymer. Biomaterials 31, 2736–2745 (2010).
El-Sabbagh, A. M. et al. Effect of air exposure and suction on blood cell activation and hemolysis in an in vitro cardiotomy suction model. ASAIO J. 59, 474–479 (2013).
Harvey, S. L. et al. Hepatic function in premature lambs supported by the artificial placenta and total parenteral nutrition. ASAIO J. 68, 949–955 (2022).
Korn, R. L. et al. The effects of carmeda bioactive surface on human blood components during simulated extracorporeal circulation. J. Thorac. Cardiovasc. Surg. 111, 1073–1084 (1996).
Willers, A. et al. New trends, advantages and disadvantages in anticoagulation and coating methods used in extracorporeal life support devices. Membranes 11, 617 (2021).
Wang, Y.-B., Shi, K.-H., Jiang, H.-L. & Gong, Y.-K. Significantly reduced adsorption and activation of blood components in a membrane oxygenator system coated with crosslinkable Zwitterionic copolymer. Acta Biomater. 40, 153–161 (2016).
Tanaka, M. et al. Blood compatible aspects of poly (2-methoxyethylacrylate)(PMEA)—relationship between protein adsorption and platelet adhesion on PMEA surface. Biomaterials 21, 1471–1481 (2000).
Wendel, H. P. & Ziemer, G. Coating-techniques to improve the hemocompatibility of artificial devices used for extracorporeal circulation. Eur. J. Cardiothorac. Surg. 16, 342–350 (1999).
Biran, R. & Pond, D. Heparin coatings for improving blood compatibility of medical devices. Adv. Drug Deliv. Rev. 112, 12–23 (2017).
Roberts, T. R. et al. Tethered liquid perfluorocarbon coating for 72 h heparin-free extracorporeal life support. ASAIO J. 67, 798–808 (2021).
Ukita, R. et al. Zwitterionic poly-carboxybetaine coating reduces artificial lung thrombosis in sheep and rabbits. Acta Biomater. 92, 71–81 (2019).
Klein, S. et al. Endoxy: dynamic long-term evaluation of endothelialized gas exchange membranes for a biohybrid lung. Ann. Biomed. Eng. 48, 747–756 (2020).
Wo, Y., Brisbois, E. J., Bartlett, R. H. & Meyerhoff, M. E. Recent advances in thromboresistant and antimicrobial polymers for biomedical applications: just say yes to nitric oxide (NO). Biomater. Sci. 4, 1161–1183 (2016).
Major, T. C. et al. The hemocompatibility of a nitric oxide generating polymer that catalyzes S-nitrosothiol decomposition in an extracorporeal circulation model. Biomaterials 32, 5957–5969 (2011).
Robinson, T. M., Kickler, T. S., Walker, L. K., Ness, P. & Bell, W. Effect of extracorporeal membrane oxygenation on platelets in newborns. Crit. Care Med. 21, 1029–1034 (1993).
Cortazzo, J. A. & Lichtman, A. D. Methemoglobinemia: a review and recommendations for management. J. Cardiothorac. Vasc. Anesth. 28, 1043–1047 (2014).
Burgos, C. M., Frenckner, B. & Broman, L. M. Premature and extracorporeal life support: is it time? A systematic review. ASAIO J. 68, 633–645 (2022).
Balasubramaniam, J. & Del Bigio, M. R. Animal models of germinal matrix hemorrhage. J. Child Neurol. 21, 365–371 (2006).
Ting, P., Yamaguchi, S., Bacher, J. D., Killens, R. H. & Myers, R. E. Failure to produce germinal matrix or intraventricular hemorrhage by hypoxia, hypo-, or hypervolemia. Exp. Neurol. 83, 449–460 (1984).
Rambaud, J., Guilbert, J., Guellec, I. & Renolleau, S. A pilot study comparing two polymethylpentene extracorporeal membrane oxygenators. Perfusion 28, 14–20 (2013).
Acknowledgements
The authors would like to thank Mark Jeakle and Joseph Hill for performing much of the laboratory testing for this manuscript.
Funding
This study was supported by the National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD073475; PI: G.B.M.).
Author information
Authors and Affiliations
Contributions
B.P.F., O.L.-C., T.C.M., and G.L. made substantial contributions to the conception or design of the work; the acquisition, analysis, or interpretation of data for the work; drafting the work or revising it critically for important intellectual content; final approval of the version to be published; and agree to be accountable for all aspects of the work. S.L.H., M.W.L., M.D.J., C.S., N.M., and R.R. made substantial contributions to the acquisition, analysis, or interpretation of data for the work; drafting the work or revising it critically for important intellectual content; final approval of the version to be published; and agree to be accountable for all aspects of the work. A.R.-P., M.E.M., R.H.B., and G.B.M. made substantial contributions to the conception or design of the work; drafting the work or revising it critically for important intellectual content; final approval of the version to be published; and agree to be accountable for all aspects of the work.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Fallon, B.P., Lautner-Csorba, O., Major, T.C. et al. Extracorporeal life support without systemic anticoagulation: a nitric oxide-based non-thrombogenic circuit for the artificial placenta in an ovine model. Pediatr Res 95, 93–101 (2024). https://doi.org/10.1038/s41390-023-02605-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41390-023-02605-2
This article is cited by
-
Ethical challenges in first-in-human trials of the artificial placenta and artificial womb: not all technologies are created equally, ethically
Journal of Perinatology (2023)
-
The artificial placenta and EXTEND technologies: one of these things is not like the other
Journal of Perinatology (2023)